Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.

Starr TN, Greaney AJ, Addetia A, Hannon WW, Choudhary MC, Dingens AS, Li JZ, Bloom JD. · 2021

Read Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. by Starr TN, Greaney AJ, Addetia A, Hannon WW, Choudhary MC, Dingens AS, Li JZ, Bloom JD. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7963219.txt.

Description

Starr and co-authors report a study mapping which mutations let SARS-CoV-2 escape antibody treatment. Several antibodies were in use or in trials against COVID-19. New variants raised the fear that they would stop working. The team built a yeast library covering every tolerable change to the virus's receptor-binding domain. They then tested how each change affected binding by three leading antibodies.

The maps flag the changes that break antibody binding. One single change escapes both antibodies in a well-known cocktail. Many escape changes for single antibodies already circulate in people. The library approach lets scientists see threats before they spread. It also shows which parts of the domain the antibodies cannot afford to lose. The work gives drug makers a forecast to design against.

Catalog record

CREATORStarr TN, Greaney AJ, Addetia A, Hannon WW, Choudhary MC, Dingens AS, Li JZ, Bloom JD.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7963219

Browse the full library · About the Tower of Babel